Home / Inspections / 1269778

FDA Inspection 1269778 — Novo Nordisk Pharmaceutical Industries LP

Novo Nordisk Pharmaceutical Industries LP — FEI 1000158576

The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries LP on June 13, 2025 in Clayton, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 13, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clayton, NC (United States)

Facility

Other inspections at this facility

  • 1041878 (NAI Fri Jan 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1035563 (NAI Thu Jan 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 892098 (NAI Thu Aug 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 802592 (NAI Thu Aug 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 734383 (NAI Fri Jul 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources